[Ovid] The Orexin 2 Receptor Agonist ALKS 2680 in Patients with Narcolepsy Type 1: An Initial Proof of Concept Phase 1b Study (P8-4.004) |
|
This post will be closed automatically in 2026-07-31 06:12
Reward20points
|
10
Clinical Experience, Characteristics, and Performance of an Acetaminophen Absorption Test in Critically Ill Patients
10
Efficacy and Safety of Anti-Xa-Guided Versus Fixed Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism in Trauma Patients
10
The Lived Experience of Cardiac Arrest Survivors
10
Financial Toxicity in Patients With Resected Lung Cancer
10
Anxiolytic effects of diazepam in Trinidadian guppies exposed to chemical cues indicating predation risk
